主动监测后延迟根治性前列腺切除术的长期结局
基于哥德堡随机人群前列腺癌筛查试验,132例筛查发现的前列腺癌患者在接受主动监测后行延迟根治性前列腺切除术。中位诊断至手术时间1.9年,术后中位随访10.9年,39%患者存在至少一项不良病理特征,10年生化复发无生存率为79.5%,且索引肿瘤在活检中常未被识别。
要点
- 延迟根治性前列腺切除术患者中39%存在不良病理特征。
- 10年前列腺特异性抗原无复发生存率为79.5%。
- 索引肿瘤在诊断活检中29%未识别,末次重复活检中21%未识别。
核心结论
- 延迟根治性前列腺切除术患者中不良病理比例较高,索引肿瘤常未被活检识别,需更好的风险分层和进展判定方案。
研究设计与样本
- 研究纳入哥德堡随机人群前列腺癌筛查试验中1995年至2014年接受延迟根治性前列腺切除术的132例筛查发现前列腺癌患者,末次随访日期为2017年5月15日。
主要发现
- 中位诊断至手术时间为1.9年(IQR 1.2-4.2),术后中位随访10.9年(IQR 7.5-14.5)。
- 52例(39%)患者至少存在一项不良病理特征。
- 10年前列腺特异性抗原无复发生存率为79.5%。
- 索引肿瘤在诊断活检中未识别38/132例(29%),在根治术前末次重复活检中未识别22/105例(21%)。
关键数值与推荐
- 主动监测期间每3至6个月检测前列腺特异性抗原,每2至4年重复活检。
- 根治性手术触发因素为基于前列腺特异性抗原、分级和/或分期的疾病进展或患者要求。
- 不良病理特征定义为Gleason评分大于3+4、前列腺外侵犯、切缘阳性、精囊侵犯和/或N+。
临床怎么用
- 主动监测中应加强风险分层和进展判定方案,以减少延迟手术时不良病理和索引肿瘤漏检。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We sought to determine long-term outcomes after deferred radical prostatectomy. MATERIALS AND METHODS: The study population consisted of all 132 men with screening detected prostate cancer who underwent deferred radical prostatectomy from January 1, 1995 to December 31, 2014 after active surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial. The last date of followup was May 15, 2017. Followup during active surveillance was performed with prostate specific antigen tests every 3 to 6 months and repeat biopsies every 2 to 4 years. Triggers for radical prostatectomy were disease progression based on prostate specific antigen, grade and/or stage, or patient request. Outcomes included adverse pathology findings at radical prostatectomy, defined as Gleason score greater than 3 + 4, extraprostatic extension, positive margins, seminal vesicle invasion and/or N+, whether the index tumor at radical prostatectomy was identified at biopsy and prostate specific antigen relapse-free survival. Kaplan-Meier analysis was performed. RESULTS: Median time from diagnosis to surgery was 1.9 years (IQR 1.2-4.2) and median postoperative followup was 10.9 years (IQR 7.5-14.5). A total of 52 men (39%) experienced at least 1 unfavorable pathology feature at radical prostatectomy. The 10-year prostate specific antigen relapse-free survival was 79.5%. The index tumor was not identified in the diagnostic biopsy in 38 of the 132 men (29%) or at the last repeat biopsy that preceded radical prostatectomy 22 of 105 (21%). CONCLUSIONS: A large proportion of men had unfavorable pathology findings at deferred radical prostatectomy and the index tumor was frequently not identified. There is a clear need for better risk classification and protocols to determine disease progression during active surveillance.
引用
- Godtman RA, Schafferer M, Pihl CG, et al. Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance. J Urol. 2018. PMID: 29730198. doi:10.1016/j.juro.2018.04.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。